Cranbury, NJ, United States
Cranbury, NJ, United States

Time filter

Source Type

Patent
Cornerstone Pharmaceuticals Inc. | Date: 2016-04-21

Pharmaceutical formulations containing lipoic acid derivatives are made.


CRANBURY, N.J., Dec. 5, 2016 /PRNewswire/ -- Cornerstone Pharmaceuticals, Inc., a privately held, clinical-stage, oncology-focused pharmaceutical company, today presented data from two Phase I trials evaluating its lead compound, CPI-613, in poster sessions at the 58th annual meeting of...


News Article | November 10, 2016
Site: www.prnewswire.com

NEWARK, N.J., Nov. 10, 2016 /PRNewswire/ -- IDT Corporation (NYSE: IDT) today announced a strategic investment in Cornerstone Pharmaceuticals, Inc., a privately-held biotechnology company. IDT and a group of "A list" co-investors invested $10 million for a minority interest in the...


Patent
Cornerstone Pharmaceuticals Inc. | Date: 2013-12-19

Therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty, acids, such as but not limited to lipoic acid, and pharmaceutical formulations comprising such analogs or derivatives and pharmaceutically-acceptable carriers therefor, are useful for the treatment, prevention, imaging, and/or diagnosis of medical disorders.


Patent
Cornerstone Pharmaceuticals Inc. | Date: 2014-02-12

Lipoic acid derivatives and pharmaceutical formulations containing lipoic acid derivatives are useful in the treatment and prevention of disease characterized by disease cells that are sensitive to lipoic acid derivatives.


Patent
Cornerstone Pharmaceuticals Inc. | Date: 2014-06-25

Lipoic acid derivatives and pharmaceutical formulations containing lipoic acid derivatives are useful in the treatment and prevention of disease characterized by disease cells that are sensitive to lipoic acid derivatives.


Patent
Cornerstone Pharmaceuticals Inc. | Date: 2014-03-27

Pharmaceutical formulations containing lipoic acid derivatives are made.


Patent
Cornerstone Pharmaceuticals Inc. | Date: 2015-09-17

Pharmaceutical formulations containing lipoic acid derivatives and ion pairs thereof are described. The pharmaceutical formulations are useful in the treatment of medical disorders, such as cancer.


News Article | November 29, 2016
Site: www.prnewswire.com

CRANBURY, N.J., Nov. 29, 2016 /PRNewswire/ -- Cornerstone Pharmaceuticals, Inc., a clinical stage, oncology-focused pharmaceutical company and an innovator in the field of cancer metabolism, today announced the hiring of Brian Mullaney, M.D., Ph.D., as Chief Medical Officer responsible...

Loading Cornerstone Pharmaceuticals Inc. collaborators
Loading Cornerstone Pharmaceuticals Inc. collaborators